Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates.

Tanner R. et al, (2021), NPJ Vaccines, 6

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.

Müller J. et al, (2019), JCI insight, 4

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.

Tanner R. et al, (2019), Journal of Immunological Methods, 469, 1 - 10

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

Tanner R. et al, (2019), Scientific reports, 9

The Humoral Immune Response to BCG Vaccination.

Tanner R. et al, (2019), Frontiers in Immunology, 10

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection.

Tanner R. et al, (2019), Frontiers in immunology, 10

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection

O’Shea MK. et al, (2018), Scientific Reports, 8

Meeting report: 5th Global Forum on TB Vaccines, 20–23 February 2018, New Delhi India

Atmakuri K. et al, (2018), Tuberculosis, 113, 55 - 64

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin

McNeill E. et al, (2018), Nature Communications, 9

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK

Hayward S. et al, (2018), F1000Research, 7, 461 - 461

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines

Harris SA. et al, (2018), Tuberculosis, 108, 99 - 105

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection.

O'Shea MK. et al, (2018), Frontiers in immunology, 9

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Pepponi I. et al, (2017), Tuberculosis, 106, 118 - 122

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010–2014

Brennan MJ. et al, (2017), Clinical and Vaccine Immunology, 24

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays

Tanner R. et al, (2017), Scientific Reports, 7

Replacing, reducing and refining the use of animals in tuberculosis vaccine research

Tanner R., (2017), ALTEX, 157 - 166

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

Kaufmann SHE. et al, (2017), Frontiers in Immunology, 8

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis

Zelmer A. et al, (2016), BMC Infectious Diseases, 16

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study

Fletcher HA. et al, (2016), BMC Medicine, 14

Erratum: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants

Fletcher HA. et al, (2016), Nature Communications, 7

Load More

Include forthcoming?